Cost-effectiveness of Anti-VEGF treatments for age-related macular degeneration: a Brazilian perspective

Renata Portella Nunes^1,2; Flávio Eduardo Hirai¹; Eduardo Buchelle Rodrigues¹; Michel Eid Farah

DOI: 10.5935/0004-2749.20200020

1. Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil
2. Instituto de Olhos de Florianópolis, Florianópolis, SC, Brazil

Corresponding author

Renata Portella Nunes
Instituto de Olhos de Florianópolis
Rua Presidente Coutinho, 579, cj 501
Florianópolis – SC - 88015-231 – Brazil
E-mail: [email protected]

Funding: This study was supported by CNPq (558868/2009-6) e FAPESP (2010/15451-0).

Disclosure of potential conflicts of interest: Dr. Rodrigues reports grants from Bayer and Allergan, outside the submitted work. There are no conflicts of interest for all other authors.

Read in Portuguese Print PDF English

How to cite this article:

Nunes^{1 RP, 2} , Hirai FE, Rodrigues EB, Farah ME. Estudo de custo-efetividade de tratamentos para a degeneração macular relacionada à idade: uma perspectiva brasileira. Arq. Bras. Oftalmol. 2020;83(1):. 10.5935/0004-2749.20200020

Export citation